Facebook
Instagram
Linkedin
Pinterest
Twitter
Youtube
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Tag: Dr Robert A Wood
Biologic Showing Promise as Food Allergy Treatment in Ongoing Phase 3...
Dave Bloom
-
2022/11/14
Assessment for both single agent and add-on therapy.
FDA Green Lights Phase 2 Trials of PVX108, a Novel Peptide-Driven...
News Wire ~ 3rd Party Press Release
-
2022/03/04
Phase 2 study of candidate from Aravax will commence in the US and Australia.
Following OIT, Certain Egg Allergy Patients Likely to Consume and Tolerate...
News Wire ~ 3rd Party Press Release
-
2019/02/24
Subjects achieving sustained unresponsiveness to egg following four years of oral immunotherapy likely to consume and tolerate eggs five years later.
Food Allergy Immunotherapy Advances Presented at AAAAI Meeting
Dave Bloom
-
2017/03/06
Here's a quick recap from this morning's AAAAI press release.